Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1997 | 09-1997 | 06-1997 | 03-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 260 | 931 | 2,176 | 2,176 | 810 |
| Marketable Securities | 2,120 | 2,534 | 2,174 | 2,174 | 2,914 |
| Receivables | 2,120 | 1,404 | 496 | 496 | 1,367 |
| Other current assets | 70 | 116 | 73 | 73 | 121 |
| TOTAL | $4,570 | $4,985 | $4,920 | $4,920 | $5,212 |
| Non-Current Assets | |||||
| PPE Net | N/A | 366 | 484 | 484 | 489 |
| Investments And Advances | 420 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,510 | 0 | 0 | 0 | 0 |
| TOTAL | $1,930 | $366 | $484 | $484 | $489 |
| Total Assets | $6,730 | $7,204 | $7,533 | $7,533 | $7,880 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 80 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 1,580 | N/A | N/A | N/A | N/A |
| Other current liabilities | 290 | N/A | N/A | N/A | N/A |
| TOTAL | $1,950 | $1,929 | $1,990 | $1,990 | $2,008 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,950 | $2,189 | $2,233 | $2,233 | $2,234 |
| Shareholders' Equity | |||||
| Common Shares | 60 | 60 | 60 | 59 | 59 |
| Retained earnings | -20,730 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | -120 | 4,955 | 5,241 | 5,241 | 5,586 |
| TOTAL | $4,770 | $5,015 | $5,300 | $5,300 | $5,646 |
| Total Liabilities And Equity | $6,720 | $7,203 | $7,533 | $7,533 | $7,880 |